baber/WOPTO huggingface dataset:
Patent CA-2450084-A1 (CA)
Title: System and method for bridging a clinical remote data entry product to a back-end clinical data management system
Inventor: KLOSS SIEBGERT R
IPC: G06Q50/22
Filed: 2002-06-06
Abstract: A back-end clinical definition is designed using a back-end clinical data management system (CDMS) (8-1). The back-end clinical definition is automatically converted into a Remote Data Entry (front-end) study definition (32-1). The front-end study definition is transferred to a remote computer hosting a front-end RDE product where it is used to regulate the acquisition of clinical data (1508). During the back-end clinical definition to front-end study definition conversion process, a conversion map is created (1706). The conversion map allows for the automated conversion of clinical data acquired using the front-end RDE product to a format that can be read by the back-end CDMS (1706). Clinical data is retrieved from remote computers hosting a front-end RDE product in an automated manner without manual back-end clinical definition/front-end study definition conflict resolution (1508).
Patent CA-2451645-A1 (CA)
Title: Enzyme treated maple syrup, shelf stable, pure maple based products, and blended products
Inventor: SWAIN ROBERT
IPC: A23L35/00
Filed: 2002-05-17
Abstract: A method for producing shelf stable, maple syrup products is provided, which comprises adding a sucrose-cleaving enzyme, for example invertase, to maple syrup and incubating the resulting solution. A shelf stable, thick, pourable pure maple syrup is provided that has the viscosity of common table syrup. Also provided is a shelf stable, spreadable maple syrup product with a consistency similar to that of clear honey, which may be used as a spread, o r sweetener or a topping. Further, a shelf stable, spreadable pure maple butte r product is provided, with the consistency of churned honey which may be used as a spread, sweetener, topping, or snack. The enzyme treated maple syrup ma y also be added to other products to increase the shelf stability of the products, by preventing the visible crystallization or separation of the products.
Patent CA-2452547-A1 (CA)
Inventor: TOTTERMAN SAARA MARJATTA SOFIA
IPC: G06F19/00
Filed: 2002-07-26
Abstract: Selon l'invention, des objets spécifiques servent d'indicateurs, ou biomarqueurs, de la maladie articulaire dans des articulations humaines ou animales. Dans une image tridimensionnelle de l'articulation (102), on identifie et on quantifie (104) les biomarqueurs. De multiples images tridimensionnelles peuvent être prises au fil du temps (106), dans lesquelles on peut suivre les biomarqueurs en fonction du temps (112). L'invention fait appel à des techniques de segmentation pour identifier le biomarqueur dans une première image et pour transposer l'identification aux images restantes.
Patent CA-2455568-A1 (CA)
Title: Stacked backplane assembly
Inventor: BATTERTON RODNEY STEPHEN
IPC: H05K7/14
Filed: 2002-06-04
Abstract: A stacked backplane assembly, including two or more backplanes or midplanes having different functionality and combined together so as to form an integral unit, is provided.      The backplanes forming the assembly axe manufactured with prime and secondary manufacturing holes to enable alignment, so that the resulting tolerance build-up of the assembly is similar to that of a single backplane. Connectors can be arranged on the backplanes of the assembly so that an electronic or optical card can be simultaneously plugged in to one or more of the backplanes that comprise the stacked backplane assembly. The stacked backplane assembly of the embodiments of the invention is illustrated by having power and signal backplanes and midplanes, but can be equally applied to backplanes that provide other types of functionality.
Patent CA-2457127-A1 (CA)
Title: Test enabled application execution
Inventor: LUNDBLADE LAURENCE
IPC: H04M1/00
Filed: 2002-08-15
Abstract: Testing system and method for executing an application on a wireless device (900) includes a management function for aiding the test-enable permissions (910) and for controlling the risk of providing a test environment associate d with the testing applications.
Patent CA-2457575-A1 (CA)
Inventor: TSUKAMOTO YOSHIHISA
IPC: C07D405/12
Filed: 2002-08-14
Abstract: A compound represented by the formula:  (see formula I) [wherein R1 represents a hydrogen atom, a halogen atom, alkyl group, etc., R2 represents a hydrogen atom, a halogen atom, alkyl group, etc., each independently represent a R3, R4, R5, R6 and R7 hydrogen atom, a halogen atom, a substitutable alkyl group, a substitutable alkenyl group, alkynyl group, a substitute--able cycloalkyl group, etc., or R3, R4, R5, R6 and R7 may form a ring which may be substituted, which is formed by the adjacent two of them with carbon atoms to which the respective substituents are bonded, m and n each independently represent 0 or 1.]  a salt thereof, an ester derivative thereof and an agricultural chemical containing the same as an effective ingredient, and a herbicidal composition containing the compound and a second herbicidally active compound as effective ingredients.
Patent CA-2458981-A1 (CA)
Inventor: GIMONA ALBERTO
IPC: A61K31/365
Filed: 2002-10-10
Abstract: L'invention se rapporte à une composition pharmaceutique utile dans le traitement d'états chez les mammifères qui sont réceptifs à l'inhibition de COX-2, et comprenant à la fois un inhibiteur de COX-2 et de l'aspirine faiblement dosée pour une utilisation simultanée, séquentielle ou séparée.
Patent CA-2462084-A1 (CA)
Title: Lithium cobalt compound oxide and manufacturing methods thereof, and non-aqueous electrolyte secondary cell
Inventor: YAMAZAKI NOBUYUKI
IPC: C01G51/04
Filed: 2004-03-26
Abstract: A non-aqueous electrolyte secondary cell having improved discharge properties is provided. The non-aqueous electrolyte secondary cell having improved discharge properties can be obtained when a lithium cobalt compound oxide, which has an average particle size in the range of 10 to 15 µ m, and a remaining lithium carbonate at a content of 0.1 percent by weight or less.
Patent CA-2464254-A1 (CA)
Title: Inhibitors of post-proline cleaving proteases
Inventor: ASHWORTH DOREEN MARY
IPC: C07D417/12
Filed: 2002-10-23
Abstract: Novel compounds that are inhibitors of one or most post-proline cleaving proteases, e.g. dipeptidyl peptidase IV, according to general formula (1). R1 is H or CN, X1 is O, S, CH2, CHF, CF2, CH(CH3), C(CH3)2 or CH(CN), and b is 1 or 2. G1 is H or a group according to the formula -CH2-X2-(CH2)a-G3 and G2 is H or a group according to the formula -CH2-(CH29a-G3, provided that one of G1 and G2 is H and the other is not H. X2 is O, S, or CH2, and a is 0, 1 or 2, provided that when a is 1 then X2 is CH2. G3 is a group according to one of general formulae 2-4., where the variables have meaning given in the description. The compounds are useful in the treatment of i.a. type 2 diabetes and impaired glucose tolerance.
Patent CA-2464510-A1 (CA)
Inventor: COLE DOUGLAS J
IPC: G06Q10/10
Filed: 2002-10-17
Abstract: A system and a method are described for providing a rule-based dynamic computer user interface for healthcare workers that emulates workflow. The system and method facilitate customization of user interface by the healthcare institution. A software model is presented that provides at least one of: a) an area for development of code (i.e., Build), b) an area that represents industry best practice business rules and work flows (i.e., Default/Model), and c) an area where customer specific adaptations reside (i.e., Client/Enterprise). Business processes are provided within the software model that describes all possible processes that might be used by a health care organization. Capability is then provided to adapt the defined business processes by scenario and/or context and in real time, changing flow of user interface screens and information presented to each user. A user interface is provided that has a consistent look and feel across all functions.
Patent CA-2465252-A1 (CA)
Inventor: BEAVER JEFFREY
IPC: E05D11/10
Filed: 2004-04-27
Abstract: A locking hinge apparatus includes first and second hinge members coupled together for rotation about an axis, a lock movable between a locking position in which the first and second hinge members are prevented from rotating about the axis and a releasing position in which the first and second hinge members are permitted to rotate about the axis, and a knob rotatable about the axis and movable along the axis. The lock moves from the locking position to the releasing position in response to movement of the knob axially toward the first and second hinge members and then rotation of the knob about the axis.
Patent CA-2465379-A1 (CA)
Inventor: SHACKLE TERRY
IPC: G06F17/30
Filed: 2002-11-11
Abstract: Système de gestion de matériel comprenant une base de données pour la mémorisation d'inventaire de données pour réseau orienté objet. Les données sur les composants du réseau sont entrés dans la base de données sous forme de différentes classes d'objets sélectionnées. Un identificateur d'objet est ajouté sélectivement, en fonction de la classe d'objets. Au moins une classe d'objets peut recevoir d'autres objets, de telle façon que les données soient mémorisées sous forme d'un arbre d'objets modifié sans avoir tous les objets contribuant à l'identificateur d'objet.
Patent CA-2467763-A1 (CA)
Title: Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
Inventor: KETELSON HOWARD ALLEN
IPC: B32B21/02
Filed: 2002-12-20
Abstract: The use of nanoparticles of inorganic materials (e.g., synthetic smectite clays) in ophthalmic and otic pharmaceutical compositions is described. The nanoparticles are utilized as biologically inert carriers or depots for ophthalmic and otic drugs. The nanoparticles may also be utilized to modify the rheological properties of the compositions, so as to enhance the viscosity or flow characteristics of the compositions and/or increase the retention time of the compositions in the eye or ear.
Patent CA-2469048-A1 (CA)
Title: Quinolinones as prostaglandin receptor ligands
Inventor: DUBE DANIEL
IPC: A61K31/4745
Filed: 2002-12-11
Abstract: This invention encompasses a method for treating a prostaglandin E mediated disease or condition comprising administering to a mammalian patient in need of such treatment a compound of Formula (A) in an amount that is effective to treat the prostaglandin E mediated disease or condition.
Patent CA-2470500-A1 (CA)
Title: Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
Inventor: WILLIAMSON JEFFREY A
IPC: A61P25/20
Filed: 2002-12-26
Abstract: The present invention is directed to aqueous based formulations of water-soluble prodrugs of propofol. The formulations comprise in aqueous medium an effective amount of the water-soluble prodrug of propofol and an effective amount of an antioxidant. In one embodiment, the formulation also contains a tonicity modifier. The formulations are particularly useful as intravenous injections. The formulations preferably are buffered to a pH suitable for minimizing degradation of the prodrug during storage. Advantageously, the formulations can be prepared without the use of harmful co-solvents or surfactants, and are stable at room temperature over extended periods of time.
Patent CA-2471537-A1 (CA)
Inventor: LEBLANC RUSSELL P
IPC: F42B12/74
Filed: 2004-06-18
Abstract: A composition and method of manufacturing a non-lead, high density matrix that may be used as a replacement for lead in those instances where lead is used, but its toxicity is undesirable. The composition comprises metal particles combined with synthetic or natural rubber, and is particularly useful in manufacturing non-lead projectiles such as shot and bullets, as well as bullet cores for jacketed bullets.
Patent CA-2473738-A1 (CA)
Title: Phthalocyanine dye mixture and ink containing the same
Inventor: YABUKI YOSHIHARU
IPC: C09D11/328
Filed: 2003-01-17
Abstract: To provide a novel compound having sufficiently high fastness to light, heat, humidity and active gas in the environment and a coloring composition using the compound, particularly, an ink for ink jet recording, an ink jet recording method and a method for improving the preservability of formed image, which can form an image having high fastness to light and ozone gas in the environment. A phthalocyanine dye mixture having a specific structure and an ink, an ink for ink jet recording, an ink jet recording method and a method for improving the preservability of formed image, using the phthalocyanine dye mixture.
Patent CA-2474337-A1 (CA)
Title: Composes utilises en tant qu'agonistes des recepteurs a<sb>3</sb> de l'adenosine
Inventor: DAVIES ROBIN HAVARD
IPC: A61K31/7076
Filed: 2003-01-27
Abstract: L'invention concerne des agonistes des récepteurs A3 des analogues de l'adénosine comprenant un azote N6 substitué par un groupe qui est habituellement -CH¿2?-CYCLE, où CYCLE représente un groupe hétéroaromatique spécifique, notamment un groupe pyrridyle ou bicyclique, par exemple le benzoxazole. Des fractions de CYCLE préférées sont substituées dans des positions spécifiques, notamment par halo ou méthyle et, dans une autre position, une dialkylamine.
Patent CA-2475013-A1 (CA)
Inventor: JANNSON TOMASZ P
IPC: F21S2/00
Filed: 2003-01-31
Abstract: Guide (12) d'ondes qui comporte une structure longitudinale possédant une première extrémité située à l'opposé d'une seconde extrémité. Ledit guide d'ondes comporte en outre une surface rainurée (14) formée sur la structure de manière adjacente à la première extrémité. La taille géométrique de la structure longitudinale est pratiquement constante tandis que la surface rainurée (14) modifie un rayon lumineux d'entrée pour réduire la divergence dudit rayon dans la direction verticale et augmenter la divergence de ce rayon dans la direction horizontale.
Patent CA-2475535-A1 (CA)
Inventor: LONGNECKER JOHN EDWARD
IPC: G06F19/00
Filed: 2004-07-22
Abstract: A method and system for controlling engine temperature by derating torque output of the engine. The method and system operate in cooperation with an electronic control module which is programmable for controlling temperature in the engine by Berating maximum engine torque output based on an engine temperature rate of change. This permits the Berating to be finely tuned to maximize available torque.
Patent CA-2478750-A1 (CA)
Title: Composition de barriere thermique, piece mecanique en superalliage munie d'un revetement ayant une telle composition, revetement de ceramique, et procede de fabrication du revetement
Inventor: MEVREL REMY
IPC: C04B35/486
Filed: 2004-08-05
Abstract: L'invention porte sur une composition de barrière thermique de faible conductivité et de forte résistance thermomécanique en céramique. De façon caractéristique, cette composition comporte une base de zircone, au moins un oxyde trivalent, permettant de stabiliser la zircone et de réduire la conductivité thermique de la zircone de manière optimale, et au moins un oxyde pentavalent permettant de diminuer le taux de lacunes d'oxygène pour le ramener sensiblement à celui d'une zircone partiellement stabilisée. De préférence, ledit oxyde trivalent est présent avec une proportion molaire constituée d'une première partie permettant de stabiliser partiellement la zircone et d'une deuxième partie qui introduit des défauts ponctuels dans le réseau et en ce que ledit oxyde pentavalent est présent avec une proportion molaire égale à ladite proportion molaire de ladite deuxième partie de l'oxyde trivalent. Application à la réalisation d'une pièce mécanique en superalliage (12), comportant un revêtement de céramique (11, 14) ayant cette composition, et une éventuelle sous-couche de liaison (13).
Patent CA-2479137-A1 (CA)
Title: Multi-stage vapor compression system with intermediate pressure vessel
Inventor: MANOLE DAN M
IPC: F25B45/00
Filed: 2004-08-26
Abstract: A vapor compression system includes a first compression mechanism that compresses the working fluid from a low suction pressure to an intermediate pressure, a second compression mechanism that compresses intermediate pressure working fluid to a higher discharge pressure, and a fluid circuit circulating the working fluid discharged from the second compression mechanism to the first compression mechanism. The fluid circuit includes, in serial order, a first high pressure heat exchanger, an expansion device and an evaporator. The system may be operated as a transcritical system employing carbon dioxide as the working fluid. An intermediate pressure vessel is in communication with the system between the first and second compression mechanisms and working fluid at an intermediate pressure is communicated with the vessel. The system may be regulated by controlling the mass of working fluid contained in the intermediate pressure vessel, e.g., by regulating the temperature or storage volume of the vessel.
Patent CA-2480805-A1 (CA)
Title: Device and method for compacting a fiber composite
Inventor: SUSS PAUL
IPC: F26B13/10
Filed: 2003-03-28
Abstract: Disclosed are a device and a method for compacting a continuously conveyed fiber composite (V) by means of heat (W) impingement. A heated treatment medium (L) is blasted towards the fiber composite (V) by means of at least one nozzle arrangement (2a, 2b). Said nozzle arrangement (2a, 2b) comprises a plurality of adjacent blasting nozzles (4) which are disposed at a distance (a) from each other. An intermediate space (5) is formed between two adjacent nozzles (4). Said intermediate space (5) between blasting nozzles (4) is essentially closed to the fiber composite (V) counter to the conveying path (F) such that an overpressure (P) can be created in a pressure chamber (6) located between the nozzle arrangement and the surface (O) of the fiber composite (V), whereby the treatment medium (L) can be blasted through the entire thickness of the fiber composite (V) even when said fiber composite has a great thickness.
Patent CA-2481161-A1 (CA)
Inventor: DERACHE FRANCIS
IPC: E02D29/02
Filed: 2004-09-30
Abstract: The barrier (13) has its face (16) exposed to impacts of moving masses made from individual blocks (1) that can be degraded by impacts and are filled with a material (6) capable of plastic/elastic deformation, e.g. shredded tires, plastic, earth, sand, gravel, stones or crushed concrete.
Patent CA-2486015-A1 (CA)
Title: Novel amino acid derivative and sweetening agent
Inventor: AMINO YUSUKE
IPC: A23L27/30
Filed: 2004-10-28
Abstract: The present invention provides a novel amino acid derivative, and a salt for thereof. The present invention further provides a sweetening agent and a food or beverage, which contains the novel amino acid derivative of the present invention to increase the sweetness of the same.
Patent CA-2486318-A1 (CA)
Inventor: GRAHAM ROBERT G
IPC: F23G7/00
Filed: 2004-10-29
Abstract: An apparatus and method for starved air gasification of solid organic materials, including biomass and other wastes, to convert the chemical energy stored in such materials to thermal energy or gaseous products that may be used in biochemical and/or chemical synthesis. Specifically, the system utilizes a gasifier having a "moving bed of ash" hearth wherein the feedstock is partially oxidized at a low temperature (less than 1500 degrees F) in a square or rectangular chamber having a vaulted, tapered or flat roof. Combustion gases from the gasifier are held at temperature using a recovery and regeneration chamber, and then undergo secondary oxidation in an oxidizer. The high temperature gases produced by the system can be utilized to advantage, for example, as the thermal energy source for a conventional heat recovery device such as a heat exchanger, steam generator, hot oil or air heater, or steam boiler.
Patent CA-2487908-A1 (CA)
Title: Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
Inventor: BRECHBIEL MARTIN W
IPC: A61K51/04
Filed: 2003-06-03
Abstract: Substituted 1,4,7-triazacyclononane-N,N',N"-triacetic acid compounds with a pendant donor amino group, metal complexes thereof, compositions thereof, an d methods of use in diagnostic imaging and treatment of a cellular disorder.</ SDOAB>
Patent CA-2491574-A1 (CA)
Title: Angio-immunotherapy
Inventor: GILBOA ELI
IPC: A61K39/00
Filed: 2003-07-03
Abstract: The present invention relates, in general, to cancer therapy and, in particular, to a method of treating cancer that involves immunization agains t an endothelial-specific product preferentially expressed during tumor angiogenesis or against a factor that contributes to the angiogenic process.
Patent CA-2492110-A1 (CA)
Title: Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor
Inventor: POSS CHRISTOPHER STANLEY
IPC: C07D451/06
Filed: 2003-07-07
Abstract: A compound of the formula (I) wherein a, b, cR1, R2, R3, R4, R5, R6, Q, W, Y , and Z are defined as above, useful as potent and selective inhibitors of MIP - 1.alpha.(CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
Patent CA-2493377-A1 (CA)
Inventor: NEWTON JOHN REGINALD
IPC: E01F9/669
Filed: 2003-07-16
Abstract: A post mounting arrangement for ground installation of a post comprising a tubular body portion (6) which is adapted to be installed into the ground and has an open end adapted to receive a post (2) to be supported. The open end of the tubular body portion comprises an enlarged flange portion defining a head portion (14) of the tubular main body portion (6). The head flange portion (14) includes a resilient retaining collar (12, 12') adapted to receive and engage the post, and a strengthening band (8). The head portion (14) comprises a first recess (22) defined therein within which the said collar (12, 12') is engaged and mounted, and a second recess (20) defined in the head portion adapted to receive the said strengthening band (8). The collar may comprise a shock absorbing element (12') having a groove (42) capable of receiving an expansion ring (44) to lock the element into place and seal it both to the post (2) and the head portion (14). Alternatively, the head portion (14) further comprises a separate cap (10) which is adapted to be fitted to and engages with said head portion (14) to enclose said recesses (20, 22) and secure said collar (12) and strengthening ring (8) within said recesses.
Patent CA-2494222-A1 (CA)
Title: Cutter bar
Inventor: SCHUMACHER GUSTAV
IPC: A01D34/16
Filed: 2003-10-07
Abstract: The invention relates to a reciprocating cutting bar for the cutting gear of an agricultural machine, comprising a longitudinal axis (4) along which the reciprocating cutting bar may be moved in a working direction for crop cutting, a finger bar (1), cutting fingers (2), which are fixed to the finger bar (1), each forming counter cutters (11), a knife (5) with a knife bar (7), having knife blades (8) fixed to the knife bar (7) which each have cutters (9), whereby the knife (5) is made to oscillate relative to the finger bar (1) along a transverse axis (6), which is arranged horizontally and perpendicular to the longitudinal axis (4), rollers (13), by means of which the knife (5) is supported against the finger bar (1) to the rear when viewed in the working direction. The rollers (13) are each mounted to rotate on a roller holder (17) and the roller holders (17) are fixed to the finger bar (1).
Patent CA-2496097-A1 (CA)
Inventor: LU DAI
IPC: A61K49/00
Filed: 2003-08-25
Abstract: L'invention concerne de nouveaux composés cannabinoïdes tricycliques. Certains de ces composés manifestent des propriétés de fluorescence. Les composés cannabinoïdes à fluorescence ont d'ordinaire une fluorescence endogène. Certains de ces composés, administrés dans des quantités efficaces du point de vue thérapeutique à un animal ou à un humain, permettent d'obtenir un taux suffisamment élevé de ces composés chez l'animal ou l'humain pour qu'une réaction physiologique se produise. La réaction physiologique est utile pour traiter toute une série d'états physiologiques.